A very positive move, shows that they are very confident with what they have so far. Also attacking on several different cancer fronts. The involvement of Hudson brings a lot of credibility plus these guys would not have come on board if they are not confident of what IVX has so far, given that their reputation is on the line.
Selling is due to I reckon impatient small shareholders. Plenty of news flow to come I reckon since they are tackling several different cancer types, hence I believe share price should be a lot higher in my view. Now trading around 12 months low.
Ann: Invion appoints cancer experts to Scientific Advisory Board, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(50.0%) |
Mkt cap ! $20.29M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $35.64K | 11.88M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 5258721 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 7399230 | 14 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IVX (ASX) Chart |